References
- American Psychiatric Association. Diagnostic and statistical manual disorders, (ed. 3. APA, Washington, DC 1980
- Arregui A., MacKay A. V. P., Iversen L. L., Spokes E. G. S. Reduction of angiotensin-converting enzyme in substantia nigra in early onset schizophrenia. New England Journal of Medicine 1979; 300: 502–503
- Bozarth M. A. Ventral tegmental reward system. Brain reward systems and abuse, J. Engel, L. Oreland. Raven Press, New York 1987; 147–164
- Chase L. S., Silverman S. Prognostic criteria in schizophrenia. A critical survey of the literature. American Journal of Psychiatry 1941; 98: 360–368
- Davis J. M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry 1976; 33: 858–861
- Ferrier I. N., Cotes P. M., Crow T. J., Johnstone E. C. Gonadotrophin secretion abnormalities in chronic schizophrenia. Psychological Medicine 1982; 12: 263–273
- Hennigfield J. E., London E. D., Jaffe J. H. Nicotine reward: studies of abuse liability and physical dependence potential. Brain reward system and abuse, J. Engel, L. Oreland. Raven Press, New York 1987; 147–164
- Hughes J. R., Hatsukami D. K., Mitchell J. E. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 1986; 143: 993–997
- Johnstone E. C., Owens D. G.C., Bydder G. M., Cotler N., Crow T. J., Frith C. D. The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychological Medicine 1989; 19: 91–103
- MacKay A. V. P. Positive and negative schiaophrenic symptoms and the role of dopamine: Discussion, 1. British Journal of Psychiatry 1980; 137: 379–383
- Spokes E. G. S., Garrett N. J., Rossor M. N., Iversen L. I. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. Journal of the Neurological Sciences 1980; 48: 303–313
- Van Kammen D. P., van Kammen W. B., Mann L. S., Seppala T., Linnoila M. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Archives of General Psychiatry 1986; 43: 978–983